{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:51:13Z","timestamp":1784119873822,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07763-0","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:02:45Z","timestamp":1729065765000},"page":"2753-2765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between ovarian tumors and exposure to assisted reproductive technologies and ovarian stimulation: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0637-0387","authenticated-orcid":false,"given":"Artur de Oliveira Macena","family":"L\u00f4bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0326-647X","authenticated-orcid":false,"given":"Vict\u00f3ria","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0706-6929","authenticated-orcid":false,"given":"Francinny Alves","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-8135","authenticated-orcid":false,"given":"Francisco Cezar Aquino","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"7763_CR1","unstructured":"Ombelet W WHO fact sheet on infertility gives hope to millions of infertile couples worldwide. Facts Views Vis ObGyn 12:249\u2013251"},{"key":"7763_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmv016","volume":"21","author":"MC Inhorn","year":"2015","unstructured":"Inhorn MC, Patrizio P (2015) Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update 21:411\u2013426. https:\/\/doi.org\/10.1093\/humupd\/dmv016","journal-title":"Hum Reprod Update"},{"key":"7763_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/humupd\/dmaa047","volume":"27","author":"TM Chiware","year":"2021","unstructured":"Chiware TM, Vermeulen N, Blondeel K et al (2021) IVF and other ART in low- and middle-income countries: a systematic landscape analysis. Hum Reprod Update 27:213\u2013228. https:\/\/doi.org\/10.1093\/humupd\/dmaa047","journal-title":"Hum Reprod Update"},{"key":"7763_CR4","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/humrep\/dew123","volume":"31","author":"J Datta","year":"2016","unstructured":"Datta J, Palmer MJ, Tanton C et al (2016) Prevalence of infertility and help seeking among 15 000 women and men. Hum Reprod Oxf Engl 31:2108\u20132118. https:\/\/doi.org\/10.1093\/humrep\/dew123","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40738-020-00093-0","volume":"7","author":"MG Madziyire","year":"2021","unstructured":"Madziyire MG, Magwali TL, Chikwasha V, Mhlanga T (2021) The causes of infertility in women presenting to gynaecology clinics in Harare, Zimbabwe; a cross sectional study. Fertil Res Pract 7:1. https:\/\/doi.org\/10.1186\/s40738-020-00093-0","journal-title":"Fertil Res Pract"},{"key":"7763_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/S0140-6736(18)32278-5","volume":"392","author":"GBD","year":"2017","unstructured":"GBD (2017) Population and Fertility Collaborators (2018) Population and fertility by age and sex for 195 countries and territories, 1950\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Lond Engl 392:1995\u20132051. https:\/\/doi.org\/10.1016\/S0140-6736(18)32278-5","journal-title":"Lancet Lond Engl"},{"key":"7763_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j138","volume":"356","author":"R Wang","year":"2017","unstructured":"Wang R, Kim BV, van Wely M et al (2017) Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ 356:j138. https:\/\/doi.org\/10.1136\/bmj.j138","journal-title":"BMJ"},{"key":"7763_CR8","volume-title":"StatPearls","author":"E Cox","year":"2024","unstructured":"Cox E, Takov V (2024) Embryology Ovarian Follicle Development. StatPearls. StatPearls Publishing, Treasure Island"},{"key":"7763_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.730196","volume":"12","author":"L Li","year":"2021","unstructured":"Li L, Shi X, Shi Y, Wang Z (2021) The Signaling Pathways Involved in Ovarian Follicle Development. Front Physiol 12:730196. https:\/\/doi.org\/10.3389\/fphys.2021.730196","journal-title":"Front Physiol"},{"key":"7763_CR10","unstructured":"Sharma M, Balasundaram P (2024) Ovulation induction techniques. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"7763_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1184\u20131203. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116427","journal-title":"Am J Epidemiol"},{"key":"7763_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS et al (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771\u2013776. https:\/\/doi.org\/10.1056\/NEJM199409223311204","journal-title":"N Engl J Med"},{"key":"7763_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/humupd\/2.1.63","volume":"2","author":"D Meirow","year":"1996","unstructured":"Meirow D, Schenker JG (1996) The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update 2:63\u201375. https:\/\/doi.org\/10.1093\/humupd\/2.1.63","journal-title":"Hum Reprod Update"},{"key":"7763_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0140-6736(71)92335-x","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation\u2013a factor in ovarian neoplasia? Lancet Lond Engl 2:163. https:\/\/doi.org\/10.1016\/s0140-6736(71)92335-x","journal-title":"Lancet Lond Engl"},{"key":"7763_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/humrep\/deae053","volume":"39","author":"AR Walker","year":"2024","unstructured":"Walker AR, Venetis CA, Opdahl S et al (2024) Estimating the impact of bias in causal epidemiological studies: the case of health outcomes following assisted reproduction. Hum Reprod Oxf Engl 39:869\u2013875. https:\/\/doi.org\/10.1093\/humrep\/deae053","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR16","first-page":"717","volume":"71","author":"DW Cramer","year":"1983","unstructured":"Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717\u2013721","journal-title":"J Natl Cancer Inst"},{"key":"7763_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.canlet.2012.05.017","volume":"324","author":"I Mertens-Walker","year":"2012","unstructured":"Mertens-Walker I, Baxter RC, Marsh DJ (2012) Gonadotropin signalling in epithelial ovarian cancer. Cancer Lett 324:152\u2013159. https:\/\/doi.org\/10.1016\/j.canlet.2012.05.017","journal-title":"Cancer Lett"},{"key":"7763_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1186\/s12885-023-11654-z","volume":"23","author":"FCA de Moraes","year":"2023","unstructured":"de Moraes FCA, Pasqualotto E, Lopes LM et al (2023) PD-1\/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials. BMC Cancer 23:1166. https:\/\/doi.org\/10.1186\/s12885-023-11654-z","journal-title":"BMC Cancer"},{"key":"7763_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","volume":"36","author":"JF Barcroft","year":"2021","unstructured":"Barcroft JF, Galazis N, Jones BP et al (2021) Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis. Hum Reprod Oxf Engl 36:1093\u20131107. https:\/\/doi.org\/10.1093\/humrep\/deaa293","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"7763_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"7763_CR22","unstructured":"Wells G, Shea B, O\u2019Connell D, et al (2000) The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis"},{"key":"7763_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"7763_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"7763_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/sim.7140","volume":"36","author":"C Partlett","year":"2017","unstructured":"Partlett C, Riley RD (2017) Random effects meta-analysis: coverage performance of 95% confidence and prediction intervals following REML estimation. Stat Med 36:301\u2013317. https:\/\/doi.org\/10.1002\/sim.7140","journal-title":"Stat Med"},{"key":"7763_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"7763_CR27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/j.fertnstert.2013.02.010","volume":"99","author":"A Asante","year":"2013","unstructured":"Asante A, Leonard PH, Weaver AL et al (2013) Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study. Fertil Steril 99:2031\u20132036. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.02.010","journal-title":"Fertil Steril"},{"key":"7763_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","volume":"99","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Trabert B, Shalev V et al (2013) In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril 99:1189\u20131196. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.12.029","journal-title":"Fertil Steril"},{"key":"7763_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/09513590701350341","volume":"23","author":"M Cusid\u00f3","year":"2007","unstructured":"Cusid\u00f3 M, F\u00e1bregas R, Pere BS et al (2007) Ovulation induction treatment and risk of borderline ovarian tumors. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 23:373\u2013376. https:\/\/doi.org\/10.1080\/09513590701350341","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"7763_CR30","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/humrep\/17.8.2209","volume":"17","author":"P Doyle","year":"2002","unstructured":"Doyle P, Maconochie N, Beral V et al (2002) Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod Oxf Engl 17:2209\u20132213. https:\/\/doi.org\/10.1093\/humrep\/17.8.2209","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR31","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/oxfordjournals.humrep.a138771","volume":"9","author":"S Franceschi","year":"1994","unstructured":"Franceschi S, La Vecchia C, Negri E et al (1994) Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod Oxf Engl 9:1673\u20131675. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a138771","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR32","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/oxfordjournals.aje.a116428","volume":"136","author":"Harris R, Whittemore AS, Itnyre J, the Collaborative Ovarian Cancer Group","year":"1992","unstructured":"Harris R, Whittemore AS, Itnyre J, the Collaborative Ovarian Cancer Group (1992) Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case-Control Studies: III. Epithelial Tumors of Low Malignant Potential in White Women. Am J Epidemiol 136:1204\u20131211. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116428","journal-title":"Am J Epidemiol"},{"key":"7763_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ygyno.2024.02.013","volume":"185","author":"AK Kristensen","year":"2024","unstructured":"Kristensen AK, Frandsen CLB, N\u00f8hr B et al (2024) Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women. Gynecol Oncol 185:108\u2013115. https:\/\/doi.org\/10.1016\/j.ygyno.2024.02.013","journal-title":"Gynecol Oncol"},{"key":"7763_CR34","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/1055-9965.EPI-12-0426","volume":"21","author":"ML Kurta","year":"2012","unstructured":"Kurta ML, Moysich KB, Weissfeld JL et al (2012) Use of fertility drugs and risk of ovarian cancer: results from a US-based case-control study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 21:1282. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0426","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"7763_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3109\/09513590.2012.671391","volume":"28","author":"L Lerner-Geva","year":"2012","unstructured":"Lerner-Geva L, Rabinovici J, Olmer L et al (2012) Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 28:809\u2013814. https:\/\/doi.org\/10.3109\/09513590.2012.671391","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"7763_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10654-019-00540-3","volume":"34","author":"FE Lundberg","year":"2019","unstructured":"Lundberg FE, Johansson ALV, Rodriguez-Wallberg K et al (2019) Assisted reproductive technology and risk of ovarian cancer and borderline tumors in parous women: a population-based cohort study. Eur J Epidemiol 34:1093\u20131101. https:\/\/doi.org\/10.1007\/s10654-019-00540-3","journal-title":"Eur J Epidemiol"},{"key":"7763_CR37","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/s0015-0282(98)00337-9","volume":"70","author":"BJ Mosgaard","year":"1998","unstructured":"Mosgaard BJ, Lidegaard O, Kjaer SK et al (1998) Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 70:1049\u20131055. https:\/\/doi.org\/10.1016\/s0015-0282(98)00337-9","journal-title":"Fertil Steril"},{"key":"7763_CR38","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/humrep\/12.10.2159","volume":"12","author":"F Parazzini","year":"1997","unstructured":"Parazzini F, Negri E, La Vecchia C et al (1997) Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod Oxf Engl 12:2159\u20132161. https:\/\/doi.org\/10.1093\/humrep\/12.10.2159","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/s0015-0282(99)00085-0","volume":"71","author":"G Potashnik","year":"1999","unstructured":"Potashnik G, Lerner-Geva L, Genkin L et al (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71:853\u2013859. https:\/\/doi.org\/10.1016\/s0015-0282(99)00085-0","journal-title":"Fertil Steril"},{"key":"7763_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/aje\/kwh315","volume":"160","author":"MA Rossing","year":"2004","unstructured":"Rossing MA, Tang M-TC, Flagg EW et al (2004) A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol 160:1070\u20131078. https:\/\/doi.org\/10.1093\/aje\/kwh315","journal-title":"Am J Epidemiol"},{"key":"7763_CR41","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.fertnstert.2008.01.073","volume":"91","author":"K Sanner","year":"2009","unstructured":"Sanner K, Conner P, Bergfeldt K et al (2009) Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 91:1152\u20131158. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.073","journal-title":"Fertil Steril"},{"key":"7763_CR42","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","volume":"100","author":"SI dos Santos","year":"2009","unstructured":"dos Santos SI, Wark PA, McCormack VA et al (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 100:1824\u20131831. https:\/\/doi.org\/10.1038\/sj.bjc.6605086","journal-title":"Br J Cancer"},{"key":"7763_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/jnci\/djaa163","volume":"113","author":"M Spaan","year":"2021","unstructured":"Spaan M, van den Belt-Dusebout AW, Lambalk CB et al (2021) Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. J Natl Cancer Inst 113:699\u2013709. https:\/\/doi.org\/10.1093\/jnci\/djaa163","journal-title":"J Natl Cancer Inst"},{"key":"7763_CR44","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/humrep\/der322","volume":"26","author":"FE van Leeuwen","year":"2011","unstructured":"van Leeuwen FE, Klip H, Mooij TM et al (2011) Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod Oxf Engl 26:3456. https:\/\/doi.org\/10.1093\/humrep\/der322","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR45","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","volume":"354","author":"A Venn","year":"1999","unstructured":"Venn A, Watson L, Bruinsma F et al (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet Lond Engl 354:1586\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(99)05203-4","journal-title":"Lancet Lond Engl"},{"key":"7763_CR46","unstructured":"World Health Organization Infertility. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/infertility. Accessed 16 May 2024"},{"key":"7763_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001356","volume":"9","author":"MN Mascarenhas","year":"2012","unstructured":"Mascarenhas MN, Flaxman SR, Boerma T et al (2012) National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 9:e1001356. https:\/\/doi.org\/10.1371\/journal.pmed.1001356","journal-title":"PLoS Med"},{"key":"7763_CR48","doi-asserted-by":"publisher","first-page":"1364352","DOI":"10.3389\/frph.2024.1364352","volume":"6","author":"RJ Aitken","year":"2024","unstructured":"Aitken RJ (2024) What is driving the global decline of human fertility? Need for a multidisciplinary approach to the underlying mechanisms. Front Reprod Health 6:1364352. https:\/\/doi.org\/10.3389\/frph.2024.1364352","journal-title":"Front Reprod Health"},{"key":"7763_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","volume":"22","author":"AT Ali","year":"2023","unstructured":"Ali AT, Al-Ani O, Al-Ani F (2023) Epidemiology and risk factors for ovarian cancer. Przeglad Menopauzalny Menopause Rev 22:93\u2013104. https:\/\/doi.org\/10.5114\/pm.2023.128661","journal-title":"Przeglad Menopauzalny Menopause Rev"},{"key":"7763_CR50","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/humrep\/dem046","volume":"22","author":"J Boivin","year":"2007","unstructured":"Boivin J, Bunting L, Collins JA, Nygren KG (2007) International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod Oxf Engl 22:1506\u20131512. https:\/\/doi.org\/10.1093\/humrep\/dem046","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR51","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/humrep\/des451","volume":"28","author":"NN Dhalwani","year":"2013","unstructured":"Dhalwani NN, Fiaschi L, West J, Tata LJ (2013) Occurrence of fertility problems presenting to primary care: population-level estimates of clinical burden and socioeconomic inequalities across the UK. Hum Reprod Oxf Engl 28:960\u2013968. https:\/\/doi.org\/10.1093\/humrep\/des451","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijgo.2013.07.001","volume":"123","author":"F Zegers-Hochschild","year":"2013","unstructured":"Zegers-Hochschild F, Dickens BM, Dughman-Manzur S (2013) Human rights to in vitro fertilization. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 123:86\u201389. https:\/\/doi.org\/10.1016\/j.ijgo.2013.07.001","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"key":"7763_CR53","doi-asserted-by":"publisher","first-page":"1240309","DOI":"10.3389\/fonc.2023.1240309","volume":"13","author":"DW Cramer","year":"2023","unstructured":"Cramer DW (2023) Incessant ovulation: a review of its importance in predicting cancer risk. Front Oncol 13:1240309. https:\/\/doi.org\/10.3389\/fonc.2023.1240309","journal-title":"Front Oncol"},{"key":"7763_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/GCO.0000000000000060","volume":"26","author":"B Diergaarde","year":"2014","unstructured":"Diergaarde B, Kurta ML (2014) Use of fertility drugs and risk of ovarian cancer. Curr Opin Obstet Gynecol 26:125\u2013129. https:\/\/doi.org\/10.1097\/GCO.0000000000000060","journal-title":"Curr Opin Obstet Gynecol"},{"key":"7763_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.beem.2018.10.002","volume":"33","author":"AM Quaas","year":"2019","unstructured":"Quaas AM, Legro RS (2019) Pharmacology of medications used for ovarian stimulation. Best Pract Res Clin Endocrinol Metab 33:21\u201333. https:\/\/doi.org\/10.1016\/j.beem.2018.10.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"7763_CR56","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jama.2024.9210","volume":"332","author":"ME Barnard","year":"2024","unstructured":"Barnard ME, Farland LV, Yan B et al (2024) Endometriosis Typology and Ovarian Cancer Risk. JAMA 332:482\u2013489. https:\/\/doi.org\/10.1001\/jama.2024.9210","journal-title":"JAMA"},{"key":"7763_CR57","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/humrep\/des466","volume":"28","author":"MA Merritt","year":"2013","unstructured":"Merritt MA, De Pari M, Vitonis AF et al (2013) Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod Oxf Engl 28:1406\u20131417. https:\/\/doi.org\/10.1093\/humrep\/des466","journal-title":"Hum Reprod Oxf Engl"},{"key":"7763_CR58","doi-asserted-by":"publisher","first-page":"k2644","DOI":"10.1136\/bmj.k2644","volume":"362","author":"CL Williams","year":"2018","unstructured":"Williams CL, Jones ME, Swerdlow AJ et al (2018) Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991\u20132010: data linkage study including 2.2 million person years of observation. BMJ 362:k2644. https:\/\/doi.org\/10.1136\/bmj.k2644","journal-title":"BMJ"},{"key":"7763_CR59","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1158\/1055-9965.EPI-16-0809","volume":"26","author":"MM Reigstad","year":"2017","unstructured":"Reigstad MM, Storeng R, Myklebust T\u00c5 et al (2017) Cancer risk in women treated with fertility drugs according to parity status-a registry-based cohort study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 26:953\u2013962. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0809","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"7763_CR60","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","volume":"100","author":"B Trabert","year":"2013","unstructured":"Trabert B, Lamb EJ, Scoccia B et al (2013) Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertil Steril 100:1660\u20131666. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.08.008","journal-title":"Fertil Steril"},{"key":"7763_CR61","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/cells10020437","volume":"10","author":"C Gr\u00fcndker","year":"2021","unstructured":"Gr\u00fcndker C, Emons G (2021) Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer. Cells 10:437. https:\/\/doi.org\/10.3390\/cells10020437","journal-title":"Cells"},{"key":"7763_CR62","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/0959-8049(94)90545-2","volume":"30A","author":"SP Langdon","year":"1990","unstructured":"Langdon SP, Crew AJ, Ritchie AA et al (1990) (1994) Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Eur J Cancer Oxf Engl 30A:682\u2013686. https:\/\/doi.org\/10.1016\/0959-8049(94)90545-2","journal-title":"Eur J Cancer Oxf Engl"},{"key":"7763_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0960-0760(94)90019-1","volume":"50","author":"SP Langdon","year":"1994","unstructured":"Langdon SP, Hirst GL, Miller EP et al (1994) The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol 50:131\u2013135. https:\/\/doi.org\/10.1016\/0960-0760(94)90019-1","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07763-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07763-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07763-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T02:02:20Z","timestamp":1734487340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07763-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7763"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07763-0","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}